-
Signature
-
/s/ Junlin Ho, Attorney-in-Fact for Mo Qatanani
-
Issuer symbol
-
SRRK
-
Transactions as of
-
14 Jan 2026
-
Net transactions value
-
-$349,650
-
Form type
-
4
-
Filing time
-
16 Jan 2026, 18:37:18 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Qatanani Mo |
CHIEF SCIENTIFIC OFFICER |
301 BINNEY STREET, CAMBRIDGE |
/s/ Junlin Ho, Attorney-in-Fact for Mo Qatanani |
16 Jan 2026 |
0001980298 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SRRK |
Common Stock |
Options Exercise |
$25,439 |
+1,407 |
+1.3% |
$18.08 |
110,371 |
14 Jan 2026 |
Direct |
F1, F2 |
| transaction |
SRRK |
Common Stock |
Options Exercise |
$2,446 |
+321 |
+0.29% |
$7.62 |
110,692 |
14 Jan 2026 |
Direct |
F1, F3 |
| transaction |
SRRK |
Common Stock |
Options Exercise |
$28,130 |
+2,813 |
+2.5% |
$10.00 |
113,505 |
14 Jan 2026 |
Direct |
F1, F4 |
| transaction |
SRRK |
Common Stock |
Options Exercise |
$92,815 |
+5,893 |
+5.2% |
$15.75 |
119,398 |
14 Jan 2026 |
Direct |
F1, F5 |
| transaction |
SRRK |
Common Stock |
Options Exercise |
$94,132 |
+2,678 |
+2.2% |
$35.15 |
122,076 |
14 Jan 2026 |
Direct |
F1, F6 |
| transaction |
SRRK |
Common Stock |
Sale |
$592,611 |
-13,112 |
-11% |
$45.20 |
108,964 |
14 Jan 2026 |
Direct |
F1, F7, F8 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SRRK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-1,407 |
-100% |
$0.000000 |
0 |
14 Jan 2026 |
Common Stock |
1,407 |
$18.08 |
Direct |
F1, F9 |
| transaction |
SRRK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-321 |
-25% |
$0.000000 |
961 |
14 Jan 2026 |
Common Stock |
321 |
$7.62 |
Direct |
F1, F10 |
| transaction |
SRRK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,813 |
-20% |
$0.000000 |
11,250 |
14 Jan 2026 |
Common Stock |
2,813 |
$10.00 |
Direct |
F1, F11 |
| transaction |
SRRK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5,893 |
-11% |
$0.000000 |
47,143 |
14 Jan 2026 |
Common Stock |
5,893 |
$15.75 |
Direct |
F1, F12 |
| transaction |
SRRK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,678 |
-7.7% |
$0.000000 |
32,142 |
14 Jan 2026 |
Common Stock |
2,678 |
$35.15 |
Direct |
F1, F13 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: